IFG Advisory’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $615K | Buy |
+7,863
| New | +$634K | 0.02% | 547 |
|
|
2026
Q1 | – | Sell |
-9,013
| Closed | -$866K | – | 680 |
|
|
2025
Q4 | $866K | Buy |
9,013
+17
| +0.2% | +$1.65K | 0.04% | 401 |
|
|
2025
Q3 | $857K | Sell |
8,996
-28,471
| -76% | -$2.62M | 0.04% | 384 |
|
|
2025
Q2 | $3.27M | Buy |
37,467
+1,918
| +5% | +$163K | 0.16% | 157 |
|
|
2025
Q1 | $3.19M | Buy |
35,549
+2,115
| +6% | +$189K | 0.18% | 145 |
|
|
2024
Q4 | $2.67M | Sell |
33,434
-1,068
| -3% | -$92.5K | 0.15% | 163 |
|
|
2024
Q3 | $3.11M | Buy |
34,502
+5,840
| +20% | +$491K | 0.2% | 140 |
|
|
2024
Q2 | $2.26M | Buy |
28,662
+2,360
| +9% | +$193K | 0.14% | 174 |
|
|
2024
Q1 | $2.29M | Sell |
26,302
-3,965
| -13% | -$338K | 0.17% | 166 |
|
|
2023
Q4 | $2.49M | Buy |
30,267
+4,771
| +19% | +$364K | 0.18% | 146 |
|
|
2023
Q3 | $2M | Buy |
25,496
+791
| +3% | +$66.2K | 0.17% | 161 |
|
|
2023
Q2 | $2.18M | Buy |
24,705
+1,663
| +7% | +$143K | 0.19% | 153 |
|
|
2023
Q1 | $1.86M | Buy |
23,042
+2,415
| +12% | +$197K | 0.17% | 147 |
|
|
2022
Q4 | $1.6M | Buy |
20,627
+584
| +3% | +$47.3K | 0.16% | 146 |
|
|
2022
Q3 | $1.62M | Buy |
20,043
+3,284
| +20% | +$295K | 0.15% | 147 |
|
|
2022
Q2 | $1.5M | Buy |
16,759
+886
| +6% | +$89.8K | 0.16% | 142 |
|
|
2022
Q1 | $1.76M | Buy |
15,873
+1,134
| +8% | +$120K | 0.18% | 142 |
|
|
2021
Q4 | $1.52M | Buy |
14,739
+467
| +3% | +$54.1K | 0.15% | 156 |
|
|
2021
Q3 | $1.79M | Buy |
14,272
+431
| +3% | +$55.8K | 0.19% | 140 |
|
|
2021
Q2 | $1.72M | Sell |
13,841
-2,303
| -14% | -$289K | 0.19% | 137 |
|
|
2021
Q1 | $1.91M | Buy |
16,144
+1,254
| +8% | +$147K | 0.24% | 108 |
|
|
2020
Q4 | $1.74M | Buy |
14,890
+1,068
| +8% | +$118K | 0.24% | 102 |
|
|
2020
Q3 | $1.44M | Buy |
13,822
+810
| +6% | +$81.3K | 0.23% | 105 |
|
|
2020
Q2 | $1.19M | Buy |
13,012
+941
| +8% | +$90.2K | 0.22% | 113 |
|
|
2020
Q1 | $1.09M | Sell |
12,071
-297
| -2% | -$31.6K | 0.24% | 100 |
|
|
2019
Q4 | $1.4M | Buy |
12,368
+243
| +2% | +$26.7K | 0.26% | 101 |
|
|
2019
Q3 | $1.32M | Sell |
12,125
-2,616
| -18% | -$273K | 0.26% | 100 |
|
|
2019
Q2 | $1.44M | Buy |
14,741
+958
| +7% | +$87.5K | 0.25% | 84 |
|
|
2019
Q1 | $1.25M | Buy |
13,783
+623
| +5% | +$55.8K | 0.24% | 94 |
|
|
2018
Q4 | $1.2M | Sell |
13,160
-685
| -5% | -$64K | 0.28% | 83 |
|
|
2018
Q3 | $1.36M | Buy |
13,845
+741
| +6% | +$68.5K | 0.26% | 94 |
|
|
2018
Q2 | $1.12M | Buy |
13,104
+350
| +3% | +$29.2K | 0.23% | 101 |
|
|
2018
Q1 | $1.02M | Buy |
12,754
+349
| +3% | +$28.8K | 0.23% | 102 |
|
|
2017
Q4 | $1M | Buy |
+12,405
| New | +$994K | 0.23% | 104 |
|
Other funds holding MDT
IFG Advisory's MDT Position: Q2 2026 in Review
IFG Advisory opened a new position in Medtronic (MDT) in Q2 2026: 7,863 shares worth $615K. The stake represents 0.02% of the portfolio and ranks #547 among its holdings. This is a return to the name: IFG Advisory previously reported a position in MDT as recently as Q4 2025.
IFG Advisory first reported a position in MDT in Q4 2017 and has held it in 34 quarters since. The position peaked at $3.27M in Q2 2025. 2,137 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- IFG Advisory held 7,863 shares of Medtronic worth $615K as of Q2 2026.
- Medtronic was a new IFG Advisory position in Q2 2026.
- Medtronic made up 0.02% of IFG Advisory's portfolio in Q2 2026, its #547 holding.
- IFG Advisory first reported a position in Medtronic in Q4 2017 and has held it in 34 quarters since.
- IFG Advisory's Medtronic position peaked at $3.27M in Q2 2025.
- 2,137 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on IFG Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.